DocSym
β
Searchsearch
Search
(D69.2) Other nonthrombocytopenic purpura
More details coming soon
2 006 370 in individuals diagnosis other nonthrombocytopenic purpura confirmed
32 024 deaths with diagnosis other nonthrombocytopenic purpura
2% mortality rate associated with the disease other nonthrombocytopenic purpura
Diagnosis other nonthrombocytopenic purpura is diagnosed Women are 1.21% more likely than Men
991 025
Men receive the diagnosis other nonthrombocytopenic purpura
14 197 (1.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 015 345
Women receive the diagnosis other nonthrombocytopenic purpura
17 827 (1.8 %)Died from this diagnosis.
Risk Group for the Disease other nonthrombocytopenic purpura - Men and Women aged 5-9
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features other nonthrombocytopenic purpura
Absence or low individual and public risk
Other nonthrombocytopenic purpura - what does this mean
Other nonthrombocytopenic purpura is a condition characterized by the spontaneous appearance of red or purple spots on the skin, caused by extravasation of blood from small vessels. it is usually caused by an autoimmune disorder, a drug reaction, or an infection, and can also be caused by certain diseases such as diabetes, lupus, or vasculitis.
What happens during the disease - other nonthrombocytopenic purpura
Other nonthrombocytopenic purpura is a type of purpura caused by a disruption of the vascular system, leading to increased vascular permeability. this disruption can be caused by a variety of factors, including autoimmune disorders, infections, medications, and physical trauma. in some cases, the exact cause of the vascular disruption may not be identified. symptoms of other nonthrombocytopenic purpura include petechiae, ecchymoses, and purpura, as well as systemic symptoms such as fever and malaise. treatment is typically supportive, and may include medications to reduce inflammation and improve vascular integrity.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Complete blood count and differential
- Urinalysis
- Serum protein electrophoresis
- Serum immunoglobulins
- Liver function tests
- Autoimmune tests
- Bone marrow biopsy
- Skin biopsy
- Imaging studies (CT scan, MRI)
- Viral studies
- Genetic testing
Treatment and Medical Assistance
Main Goal: To reduce inflammation and prevent further bleeding.
- Prescribe corticosteroid medications to reduce inflammation.
- Encourage increased fluid intake to prevent dehydration.
- Advise bed rest and elevation of the affected area.
- Prescribe non-steroidal anti-inflammatory drugs (NSAIDs).
- Administer platelet transfusions, if necessary.
- Prescribe anticoagulant medications to reduce the risk of blood clots.
- Provide nutritional and lifestyle counseling.
- Refer to a specialist for further evaluation and treatment.
13 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Other nonthrombocytopenic purpura - Prevention
Nonthrombocytopenic purpura can be prevented by avoiding activities that may cause trauma to the skin, such as contact sports, and by wearing protective clothing and gear when engaging in such activities. additionally, it is important to practice good hygiene, including washing hands regularly and avoiding contact with people who have infections, as this can help to reduce the risk of developing the condition.